Clinical Trials Sponsored by Matrix Pharmaceutical

Total 21738 results

Universidad Complutense de Madrid

Completed

Factors Influencing Bone Block Allograft Resorption

Graft Loss
Universidad Politecnica de Madrid

Completed

Effects of a Therapeutic Exercise Program for Injuries Prevention in Wheelchair Basketball (WB) Players

Shoulder Pain | Athletic Injuries | Shoulder Injury

Spain
Universidad Autonoma de Madrid

Completed

Effects of Motor Imagery and Action Observation on Electromyographic Activity and Intramuscular Oxygenation in the Hand Gripping Gesture

Asymptomatic Subjects | Painfree Voluntiers | Neuroscience

Spain
Hospital San Carlos, Madrid

Unknown

Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease (ECP-EA)

Alzheimer Disease

Spain
Universidad Politecnica de Madrid

Completed

Physical Activity and Chronic Acquired Brain Injury (PASBI)

Quality of Life | Brain Injuries | Motor Activity
Universidad Europea de Madrid

Completed

Hypoalgesic Effect of Neural Mobilization Versus Ibuprofen Pharmacologic Treatment

Cervicobrachial Neuralgia

Venezuela
Martin Angst

Completed

Immune-modulation Effects of an Arginine Rich Nutritional Supplement in Surgical Patients

Immunity

United States
Universidad Europea de Madrid

Completed

Comparison of Gut Microbiota in Sedentary and Active Women

Sedentary

Spain
Universidad Autonoma de Madrid

Completed

Video Game Exercise Effectiveness of a Domiciliary Pulmonary Rehabilitation Program in Cystic Fibrosis Patients

Cystic Fibrosis

Spain
Universidad Europea de Madrid

Completed

Whole Muscle Exercise Training (WHOLEi+12) in Pulmonary Hypertension (WHOLEi+12)

Exercise Therapy

Spain
Hospital San Carlos, Madrid

Completed

Prospective Comparison Between SADI-S and Gastric Bypass (SADI-S-GB)

Diabetes | Morbid Obesity

Spain
Martin Angst

Completed

Optimization of Time-of-Flight Mass Cytometry (CyTOF) Analysis for Evaluation of Immune Changes Following Surgery

Surgical Trauma

United States
Technical University of Madrid

Unknown

Effect of Physical Exercise Program on Outcomes and Level of Depression

Pregnancy

Spain
Universidad Complutense de Madrid

Completed

Effects of Exercise and Relaxation Techniques on Tension Headache Pain Parameters of University Students (ERTTHU)

Tension-Type Headache
Universidad Politecnica de Madrid

Unknown

Effect of Combined Exercise Post-treatment Intervention in Lean Mass Recovery in Breast Cancer Survival. (WIM1)

Depression | Quality of Life | Fatigue | Sarcopenic Obesity in Breast Cancer Survival | Muscle Strength Quantitative Trait Locus 1 | Cardiopulmonary Capacity

Spain
Universidad Complutense de Madrid

Unknown

Study of a Probiotic Strain to Prevent Mastitis and to Eradicate GBS Colonization (PROBIOPREG)

Mastitis

Spain
Grupo Hospital de Madrid

Completed

Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients (TT)

Progression Free Survival

Spain
Universidad Complutense de Madrid

Unknown

Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot Ulcers

Diabetic Foot Ulcers | Diabetic Foot | Osteomyelitis

Spain
Institut Bergonié
Bristol-Myers Squibb; Amgen; Aventis Pharmaceuticals; Sanofi-Synthelabo; Chugai Pharmaceutical

Completed

Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment (PHRC2003)

Digestive System Diseases | Lymphoma | Ovarian Diseases | Pulmonary Disease | Bladder Disease | Prostatic Disease

France
Foresee Pharmaceuticals Co., Ltd.
QPS Holdings LLC; Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Puberty; Precocious, Central

United States, China, Taiwan, Puerto Rico
Henan Cancer Hospital
Qilu Pharmaceutical Co., Ltd.; Beijing Biostar Pharmaceuticals Co., Ltd.

Not yet recruiting

Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer

HER-2 Negative Breast Cancer
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 3 of 4)

Healthy Volunteers

United States
Portola Pharmaceuticals

Withdrawn

CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)

AITL | Peripheral T-Cell Lymphoma (PTCL NOS) | Nodal Lymphomas of T Follicular Helper (TFH) | Follicular T-cell Lymphoma (FTCL) | ALCL | HSTCL | EATL I,II | MEITL, EATL Type II | Nasal Lymphoma
Portola Pharmaceuticals

Completed

A Study in Older Subject to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Rivaroxaban

Bleeding

United States
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals

Completed

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pozelimab in Combination With Cemdisiran in Healthy Adult Volunteers

Healthy

Belgium
Ferring Pharmaceuticals
Xanodyne Pharmaceuticals

Completed

A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding

Menorrhagia

United States
Daniela Matei, MD
Sanofi; Novartis Pharmaceuticals; Walther Cancer Institute

Completed

Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer

Ovarian Cancer

United States
ISA Pharmaceuticals
Regeneron Pharmaceuticals

Active, not recruiting

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Squamous Cell Carcinoma of the Oropharynx | HPV16 Positive

Netherlands, United States, United Kingdom, France, Belgium, Czechia, Spain, Italy, Germany, Brazil, Hungary, Mexico, Poland
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 2 of 4)

Healthy Volunteers
Portola Pharmaceuticals

Completed

Phase 2 Healthy Volunteer Study to Evaluate the Ability of PRT064445 to Reverse the Effects of Several Blood Thinner Drugs on Laboratory Tests (Module 4 of 4)

Healthy Volunteers
Portola Pharmaceuticals

Completed

The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist

Hepatic Impairment

United States
Portola Pharmaceuticals

Withdrawn

BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes

Venous Thromboses

United States
Jazz Pharmaceuticals
GW Pharmaceuticals

Completed

An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Seizures | Tuberous Sclerosis Complex

United States
Solvay Pharmaceuticals
Unimed Pharmaceuticals

Completed

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

Primary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)

United States
Solvay Pharmaceuticals
Unimed Pharmaceuticals

Completed

Pharmacokinetic Evaluation of Testosterone Gel (1%)

Primary or Secondary Hypogonadism | Constitutional Delay in Growth and Puberty (CDGP)

United States
ISA Pharmaceuticals
Regeneron Pharmaceuticals

Active, not recruiting

A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC

Squamous Cell Carcinoma of the Oropharynx

United States, Israel, Belgium, Germany, Spain, United Kingdom, Italy, France, Czechia
Portola Pharmaceuticals

Completed

A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

Bleeding

United States
Jazz Pharmaceuticals
GW Pharmaceuticals

Terminated

A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

Rett Syndrome | RTT

United States, Canada, Italy, Spain, United Kingdom, Australia
Alexion Pharmaceuticals
Portola Pharmaceuticals

Completed

Phase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHL

Follicular Lymphoma (FL/Indolent NHL) | Aggressive NHL (a NHL) | Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL) | T-cell Lymphoma (PTCL and CTCL) | B-cell Non Hodgkin Lymphoma (NHL)

United States
Universidad Complutense de Madrid

Recruiting

To Evaluate Postoperative Pain and Quality of Life After Taking a Deephethelized Gingival Graft and Covering it With Different Treatments

Quality of Life | Pain, Postoperative | Palate; Wound

Spain
Universidad Europea de Madrid

Recruiting

Evaluation of the Influence of a Core Muscle Control-Based Rehabilitation Program Patients With Multiple Sclerosis

Multiple Sclerosis | Pelvic Floor Disorders | Incontinence, Urinary

Spain
Universidad Europea de Madrid

Not yet recruiting

Efectivity of Non-invasive Neuromodulation in Parasympathic Nervous System and Vascular System

Hypertension
Universidad Europea de Madrid

Not yet recruiting

Effectiveness of Non-invasive Neuromodulation for Intestinal Transit in Healthy Subjects

Constipation
Universidad Europea de Madrid

Recruiting

Postural and Muscle Fatigue Analysis of Endodontic Residents

Postural; Defect | Endodontic Disease | Symptoms and Signs | Position Sense Disorders | Musculoskeletal System Disease

Spain
Universidad Complutense de Madrid

Recruiting

Emdogain Adjunctive to Autotransplantation (ATTEMD)

Autologous Transplantation | Emdogain | Autotransplantation | Enamel Matrix Derivatives

Spain
Universidad Europea de Madrid

Recruiting

Continuous Subcutaneous Glucose Monitoring in Critical Patients

Hyperglycemia | Hypoglycemia | Diabetes | Critical Care | Critically Ill Patients

Spain
Universidad Europea de Madrid

Recruiting

Update on the Detection of Frailty in the Older Adult

Depression | Quality of Life | Pain | Anxiety | Sarcopenia | Kinesiophobia | Strength | Functionality | Functional Independence

Spain
Universidad Complutense de Madrid

Recruiting

Clinical Efficacy of Different Revision Times in the Reulceration Rate in Persons With Diabetes and Remission (Diatime)

Diabetic Foot

Spain
Universidad Complutense de Madrid

Recruiting

Effects of Pressure Release of Myofascial Trigger Points on Mechanical Neck Pain.

Trigger Point Pain, Myofascial | Myofascial Pain Syndrome of Neck | Myofacial Pain

Spain
Universidad Complutense de Madrid

Recruiting

Clinical Evaluation of the Effect of the Scanning Pattern on Complete-arch Implant Scans (strategiesIOS)

Dental Prosthesis, Implant-Supported

Spain

Clinical Trials Sponsored by Matrix Pharmaceutical

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations